Bristol-Myers Squibb buy Piper Sandler
Start price
23.02.26
/
50%
€51.31
Target price
23.02.27
€63.41
Performance (%)
-0.31%
Price
17.04.26
€51.15
Summary
This prediction is currently active. The BUY prediction by Piper_Sandler for Bristol-Myers Squibb is nearly unchanged. This prediction currently runs until 23.02.27. The prediction end date can be changed by Piper_Sandler at any time. Piper_Sandler has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Bristol-Myers Squibb | 2.341% | 2.341% |
| iShares Core DAX® | 3,59 % | 3,93 % |
| iShares Nasdaq 100 | 5,81 % | 5,52 % |
| iShares Nikkei 225® | 4,08 % | 8,46 % |
| iShares S&P 500 | 4,14 % | 4,04 % |
Comments by Piper_Sandler for this prediction
In the thread Bristol-Myers Squibb diskutieren
Bristol Myers Squibb (NYSE:BMY) had its "overweight" rating reaffirmed by analysts at Piper Sandler. They now have a $75.00 price target on the stock, up previously from $66.00.
Ratings data for BMY provided by MarketBeat